The US biological data visualization market is estimated to grow significantly during the forecast period. The market is mainly driven due to the increasing amount of big data coupled with the use of next-generation sequencing (NGS) technologies and their applications to personalized medicine. Clinical labs have been significantly adopting NGS to diagnose hereditary disorders owing to its high-throughput and analytic accuracy. Moreover, the growing integration of AI in the biological sample visualization further provides significant opportunities to the market. The US biological data visualization market is segmented on the basis of technology, application, and end-user.
Based on the technology, the market is further classified into magnetic resonance imaging, microscopy, sequencing, and others(x-ray crystallography). The microscopy segment is projected to have considerable growth in the US market owing to the high application of microscopes in biological data visualization. Based on the application, the US biological data visualization market is further segmented into genomic analysis, cell biology, molecular & structural analysis, and others. The genomic analysis segment is estimated to grow at a considerable CAGR during the forecast period. Based on end-users, the biological data visualization market is further classified into pharmaceutical & biotechnology companies, research institutes, and hospitals & clinics.
The companies which are contributing to the growth of the US biological data visualization market include Agilent Technologies, Inc., Becton, Dickinson and Co., Bruker Corp., Danaher Corp., Thermo Fisher Scientific, Inc., Molecular Devices, LLC, and others. Product launch, merger, and acquisition, collaborations with government, and technological advancements through which market players are considerably contributing to the market growth to stay competitive in the market.
Research Methodology
The market study of the US biological data visualization market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for biological sample visualization market players, tissue banks, biobanks, biotechnology and pharmaceutical companies, research institutes, academic institutes, government agencies, and regulatory bodies, investing companies and venture capitalists, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. US Biological Data Visualization Market by Technology
4.1.1. Magnetic Resonance Imaging
4.1.2. Microscopy
4.1.3. Sequencing
4.1.4. Others (X-ray Crystallography)
4.2. US Biological Data Visualization Market by Application
4.2.1. Genomic Analysis
4.2.2. Cell Biology
4.2.3. Molecular and Structural Analysis
4.2.4. Others( Alignments, Phylogeny)
4.3. US Biological Data Visualization Market by End-User
4.3.1. Pharmaceutical & Biotechnology Companies
4.3.2. Research Institutes
4.3.3. Hospitals and Clinics
5. Company Profiles
5.1. 3M Co.
5.2. Agilent Technologies, Inc.
5.3. Becton, Dickinson, and Co.
5.4. Bruker Corp.
5.5. Clarivate Analytics
5.6. Danaher Corp.
5.7. Media Cybernetics, Inc.
5.8. Molecular Devices, LLC
5.9. Thermo Fisher Scientific, Inc.
5.10. TIBCO Software Inc.
1. US BIOLOGICAL DATA VISUALIZATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2019-2026 ($ MILLION)
2. US BIOLOGICAL DATA VISUALIZATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
3. US BIOLOGICAL DATA VISUALIZATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
1. US BIOLOGICAL DATA VISUALIZATION MARKET SHARE BY TECHNOLOGY, 2019 VS 2026 (%)
2. US BIOLOGICAL DATA VISUALIZATION MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
3. US BIOLOGICAL DATA VISUALIZATION MARKET SHARE BY END-USER, 2019 VS 2026 (%)
4. US BIOLOGICAL DATA VISUALIZATION MARKET SIZE, 2019-2026 ($ MILLION)